Palvella Therapeutics Ownership | Who Owns Palvella Therapeutics?

Palvella Therapeutics Ownership Summary

Palvella Therapeutics is owned by 40.48% institutional investors, 21.36% insiders, and 38.17% retail investors. Bvf inc/il is the largest institutional shareholder, holding 10.51% of PVLA shares.

PVLA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Palvella Therapeutics	40.48%	21.36%	38.17%
Sector	Healthcare Stocks	232.20%	10.74%	-142.94%
Industry	Biotech Stocks	382.11%	10.55%	-292.66%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bvf inc/il	1.16M	10.51%	$72.80M
Suvretta capital management	822.40K	7.44%	$51.56M
Frazier life sciences management	722.40K	6.54%	$45.29M
Vanguard group	560.62K	5.07%	$58.68M
Blackrock funding, inc. /de	559.07K	5.05%	$58.52M
First light asset management	541.54K	4.90%	$33.95M
Perceptive advisors	395.09K	3.57%	$24.77M
Jennison associates	387.48K	3.50%	$40.56M
Federated hermes	368.04K	3.33%	$38.52M
Woodline partners lp	345.75K	3.13%	$21.68M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Clio asset management	91.64K	7.45%	$9.59M
First light asset management	541.54K	3.20%	$33.95M
Bvf inc/il	1.16M	2.95%	$72.80M
Samsara biocapital	209.63K	1.72%	$13.14M
Frazier life sciences management	722.40K	1.36%	$45.29M
Suvretta capital management	822.40K	1.32%	$51.56M
Lisanti capital growth	41.47K	1.03%	$4.34M
Perceptive advisors	395.09K	0.72%	$24.77M
Awm investment company	69.42K	0.70%	$7.27M
Bioimpact capital	67.42K	0.69%	$4.23M

Top Buyers

Holder	Shares	% Assets	Change
First light asset management	541.54K	3.20%	541.54K
Bvf inc/il	1.16M	2.95%	464.69K
Perceptive advisors	395.09K	0.72%	395.09K
Point72 asset management	317.31K	0.03%	317.31K
Jennison associates	387.48K	0.02%	280.57K

Top Sellers

Holder	Shares	% Assets	Change
Adams street partners	-	-	-298.99K
Nantahala capital management	-	-	-250.06K
Opaleye management	-	-	-172.36K
Goldman sachs group	98.94K	0.00%	-137.69K
Samsara biocapital	209.63K	1.72%	-130.11K

New Positions

Holder	Shares	% Assets	Change	Value
First light asset management	541.54K	3.20%	541.54K	$33.95M
Perceptive advisors	395.09K	0.72%	395.09K	$24.77M
Point72 asset management	317.31K	0.03%	317.31K	$19.89M
Bioimpact capital	67.42K	0.69%	67.42K	$4.23M
Ikarian capital	64.75K	0.41%	64.75K	$4.06M

Sold Out

Holder	Change
Sbi securities	-12.00
Srs capital advisors	-91.00
Balyasny asset management	-8.18K
Jane street group	-10.02K
Xtx topco	-17.70K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	90	-11.76%	4,478,390	-47.47%	40	0.68%	61	-8.96%	15	-21.05%
Sep 30, 2025	52	-16.13%	2,330,158	-59.04%	21	0.80%	33	-19.51%	11	22.22%
Jun 30, 2025	65	62.50%	5,909,711	15.35%	53	2.47%	44	91.30%	9	125.00%
Mar 31, 2025	40	21.21%	5,124,167	27.05%	230	0.70%	24	71.43%	4	-33.33%
Dec 31, 2024	33	37.50%	4,033,115	565.98%	181	24.48%	14	40.00%	6	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Feb 27, 2026	JENKINS GEORGE M	-	Buy	$500.00K
Feb 27, 2026	HERON ELAINE J	-	Buy	$300.00K
Feb 18, 2026	Goin Kathleen	Chief Operating Officer	Sell	$102.04K
Feb 18, 2026	Goin Kathleen	Chief Operating Officer	Sell	$239.53K
Jan 21, 2026	Goin Kathleen	Chief Operating Officer	Sell	$367.18K

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	4
2025 Q4	-	3
2025 Q2	2	-
2025 Q1	-	-
2024 Q4	1	-

PVLA Ownership FAQ

Who Owns Palvella Therapeutics?

Palvella Therapeutics shareholders are primarily institutional investors at 40.48%, followed by 21.36% insiders and 38.16% retail investors. The average institutional ownership in Palvella Therapeutics's industry, Biotech Stocks , is 382.11%, which Palvella Therapeutics falls below.

Who owns the most shares of Palvella Therapeutics?

Palvella Therapeutics’s largest shareholders are Bvf inc/il (1.16M shares, 10.51%), Suvretta capital management (822.4K shares, 7.44%), and Frazier life sciences management (722.4K shares, 6.54%). Together, they hold 24.48% of Palvella Therapeutics’s total shares outstanding.

Does Blackrock own Palvella Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Palvella Therapeutics.

Who is Palvella Therapeutics’s biggest shareholder by percentage of total assets invested?

Clio asset management is Palvella Therapeutics’s biggest shareholder by percentage of total assets invested, with 7.45% of its assets in 91.64K Palvella Therapeutics shares, valued at 9.59M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools